Merck (MKGAF) Stock Price, Quote, News & History

Merck KGaA (MKGAF) Stock Price, Quote, News & History

MKGAFOTCPK

Trade with Public

$120.51

-7.09-5.55%

At close: Mar 19, 5:00 PM EST

Key Statistics

Open

$120.51

Volume / Avg.

0 / 617.00

Day Range

- - -

52 Wk Range

118.05 - 159.34

Market Cap

$52.40B

P/E Ratio

15.46

Dividend Yield

2.12%

Exchange

OTC

RSI

Short Interest

Days to Cover

861.72

Recent Merck KGaA News

Sanofi Shocker: CEO Paul Hudson Out As Board Demands 'Increased Rigor'

Sanofi appoints Belén Garijo as CEO, Paul Hudson's tenure ends on Feb 17, 2026. Garijo will prioritize strengthening R&D and governance.

Vandana Singh

Invo Fertility Stock Is Plunging After White House Announcement

INVO Fertility Inc (NASDAQ:IVF) shares are trading lower on Thursday as investors book profits following White House announcements aimed at making fertility treatments more affordable and accessible.

Evette Mitkov

FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times

The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, and other conditions.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

3.87B

Investing Cash Flow (TTM)

-4.31B

Financing Cash Flow (TTM)

-408.00M

Free Cash Flow (TTM)

1.93B

Capital Expenditure (TTM)

-1.94B

Net Change in Cash (TTM)

-847.00M

Valuation Metrics

Enterprise Value

$63.00B

PE Ratio (TTM)

15.46

PE Ratio (FWD)

12.99

PEG Ratio (TTM)

1.49

PS Ratio (TTM)

2.15

PB Ratio (TTM)

1.58

Earnings Yield % (TTM)

6.47%

Earnings Yield % (FWD)

7.70%

EV / EBITDA (TTM)

9.08

Price / EBITDA (TTM)

7.63

Price / Free Cash Flow (TTM)

23.65

Book Value / Share

$76.29

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

$809.00M

LT Debt Repayment (TTM)

-$480.00M

Total Cash

$2.25B

Debt to Equity

0.42

Issuance of Debt (TTM)

$329.00M

Repayment of Debt (TTM)

-$2.77B

Key Statistics

Open

$120.51

Volume / Avg.

0 / 617.00

Day Range

- - -

52 Wk Range

118.05 - 159.34

Market Cap

$52.40B

P/E Ratio

15.46

Dividend Yield

2.12%

Exchange

OTC

RSI

Short Interest

Days to Cover

861.72

About

Sector

Health Care

Industry

Pharmaceuticals

Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. T...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Merck (MKGAF) stock?

You can purchase shares of Merck (OTCPK:MKGAF) through any online brokerage.

View our list of the best stock brokerages

Who are Merck (MKGAF) competitors?

There are no as such competitors for Merck.

What is the forecast, or price target, for Merck (MKGAF) stock?

There is no analysis for Merck to provide a consensus price target.

What is the current price for Merck (MKGAF)?

The stock price for Merck (OTCPK: MKGAF) is $120.51 last updated March 20, 2026 at 3:51 PM EDT.

Does Merck (MKGAF) pay a dividend?

There are no upcoming dividends for Merck.

When is Merck (OTCPK:MKGAF) reporting earnings?

Merck does not have any upcoming earnings scheduled.

Is Merck (MKGAF) going to split?

There is no upcoming split for Merck.

What sector and industry does Merck (MKGAF) operate in?

Merck is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.

Key Statistics

Open

$120.51

Volume / Avg.

0 / 617.00

Day Range

- - -

52 Wk Range

118.05 - 159.34

Market Cap

$52.40B

P/E Ratio

15.46

Dividend Yield

2.12%

Exchange

OTC

RSI

Short Interest

Days to Cover

861.72

Recent Merck KGaA News

Sanofi Shocker: CEO Paul Hudson Out As Board Demands 'Increased Rigor'

Sanofi appoints Belén Garijo as CEO, Paul Hudson's tenure ends on Feb 17, 2026. Garijo will prioritize strengthening R&D and governance.

Vandana Singh

Invo Fertility Stock Is Plunging After White House Announcement

INVO Fertility Inc (NASDAQ:IVF) shares are trading lower on Thursday as investors book profits following White House announcements aimed at making fertility treatments more affordable and accessible.

Evette Mitkov

FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times

The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, and other conditions.

Vandana Singh